There are 128 resources available
Q&A and live discussion
Presenter: Dan Landau
Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy
Resources:
Webcast
Q&A and live discussion
Presenter: Irene Braña
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Webcast
The clinical perspective: Trials fit for purpose in 2020 and beyond
Presenter: Irene Braña
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
The HTA perspective: Is tissue-independent approval the next top model?
Presenter: Sonia Garcia Perez
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
The regulatory perspective: How to look for certainty in terra incognita
Presenter: Francesco Pignatti
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
Implementation of NGS diagnostics in the NHS: The example of Belgium
Presenter: Marc Van Den Bulcke
Session: Reshaping the model of evidence generation in the era of molecularly driven tissue-independent therapeutics
Resources:
Slides
Webcast
New targeted therapies for ER positive breast cancer
Presenter: Cristina Saura Manich
Session: Recent updates in treatment strategies
Resources:
Slides
Webcast
The next generation of HER2 targeting therapies
Presenter: Veronique Dieras
Session: Recent updates in treatment strategies
Resources:
Slides
Webcast
New approaches for triple negative breast cancer (non-IO approaches)
Presenter: Rebecca Dent
Session: Recent updates in treatment strategies
Resources:
Slides
Webcast
Artificial intelligence in cancer imaging: Clinical challenges and applications
Presenter: Eric Deutsch
Session: Applications of artificial intelligence (AI) in oncology drug development
Resources:
Slides
Webcast